Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
771 Leser
Artikel bewerten:
(2)

The Power Play by The Market Herald Releases New Interviews with Jourdan Resources, Gamelancer Media, Dundee Corp and MAS Gold Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / November 16, 2022 / The Power Play by The Market Herald has announced the release of new interviews with Jourdan Resources, Gamelancer Media, Dundee Corp and MAS Gold discussing their latest news.

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Jourdan Resources (TSXV:JOR) signs agreements for lithium project

The Market Herald, Wednesday, November 16, 2022, Press release picture

Jourdan Resources (JOR) has signed an earn-in agreement and joint venture agreement with Sayona Mining Limited relating to the Vallée Lithium Project. Jourdan agreed to sell up to a 51-per-cent stake in 28 claims within the project. Executive Chairman Dr. Andy Rompel sat down with Sabrina Cuthbert to discuss the news.

For the full interview with Dr. Andy Rompel and to learn about Jourdan Resources, click here.

Gamelancer Media (CSE:GMNG) partnering with RBC to promote financial literacy

The Market Herald, Wednesday, November 16, 2022, Press release picture

RBC approached Gamelancer with the idea of partnering to create an immersive experience for Gen Z and Millennial customers. Gamelancer knew it was a great fit and rolled out the first campaign on November 11th. President & Chief Operating Officer of Gamelancer Media, Mike Cotton, sat down with Sabrina Cuthbert to discuss the partnership with RBC.

For the full interview with Mike Cotton and to learn about Gamelancer, click here.

Dundee Corporation (TSX:DC.A) portfolio holding, TauRx Pharmaceuticals secures funding for regulatory submissions of its Alzheimer's treatment

The Market Herald, Wednesday, November 16, 2022, Press release picture

Dundee Corporation (DC.A) portfolio holding, TauRx Pharmaceuticals, has raised US$119 million to fund TauRx's regulatory submissions in the UK, US and Canada. Proceeds will also be used to advance development plans for regulatory approval in China. President and CEO Jonathan Goodman sat down with Sabrina Cuthbert to discuss the news.

For the full interview with Jonathan Goodman and to learn about Dundee Corporation, click here.

MAS Gold Corp (TSXV:MAS) and Kitsaki Management Limited Partnership sign MOU

The Market Herald, Wednesday, November 16, 2022, Press release picture

MAS Gold (MAS) has signed a non-binding Memorandum of Understanding (MOU) with Kitsaki Management Limited Partnership. The MOU is in respect of MAS's exploration efforts in the La Ronge Gold Belt region in Saskatchewan. Partnering with Kitsaki will allow MAS to work towards consent for its exploration and evaluation activities.

For the full interview with James Engdahl and to learn about MAS Gold, click here.

Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visit? The Power Play by The Market Herald.

About The Market Herald

The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.

DISCLAIMER: Report Card Canada Media Ltd. ("Report Card") is a wholly-owned subsidiary of Market Herald Limited, an Australian company ("Market Herald"). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald's affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website - themarketherald.ca - is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone 'bad'. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their "Terms of Service" before engaging in any business or uploading any information.

CONTACT:

The Market Herald
marketing@themarketherald.ca
themarketherald.ca

SOURCE:?The Market Herald

View source version on accesswire.com:
https://www.accesswire.com/726348/The-Power-Play-by-The-Market-Herald-Releases-New-Interviews-with-Jourdan-Resources-Gamelancer-Media-Dundee-Corp-and-MAS-Gold-Discussing-Their-Latest-News

© 2022 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.